Cabergoline
- Product NDC
- 69238-2693
- 11-digit product format
- 692382693
- Labeler code
- 69238
- Product ID
- 69238-2693_3e2ff3e8-fa09-469e-b545-68ab6b168de7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cabergoline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA218618
- Marketing category
- ANDA
- Marketing start
- 2024-10-03
- Substance
- CABERGOLINE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Ergolines [CS], Ergot Derivative [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cabergoline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CABERGOLINE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LL60K9J05T |
| Rxcui | 199703 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69238-2693-1 | Cabergoline | 8 in 1 BOTTLE | TABLET | 8 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-2693 | CABERGOLINE TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 1 | Current NDC, 1 package rows | 20241004_a246b015-e19c-4b4f-9089-aea1108687ba.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69238-2693-1 | 69238269301 | 8 TABLET in 1 BOTTLE (69238-2693-1) | 8 tablet | 2024-10-03 | No | No | Historical |